XXXuejin Xu

Xuejin Xu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xuejin Xu has a total of 1 co-authors. Here are the top co-authors by number of shared publications:

  • Zhen Wang

    Department of Stomatology, The Quzhou Affiliated Hospital of Wenzhou Medical University (Quzhou People’s Hospital), Quzhou, China

    2 shared publications

Latest Publications

  • Open Access

    A two-decade bibliometric analysis of drug resistance in oral cancer research: patterns, trends, and future directions

    by Xuejin Xu, Zhen Wang

    Background Drug resistance in oral cancer presents a significant challenge in clinical treatment. Understanding the research landscape through bibliometric analysis can provide valuable insights into the development and trends in this field. Objective To comprehensively analyze the global research trends, collaboration patterns, and emerging topics in oral cancer drug resistance research from 2000 to 2024 using bibliometric methods. Methods Publications related to oral cancer drug resistance were retrieved from the Web of Science core collection database. CiteSpace and VOSviewer were employed to analyze publication trends, research collaboration networks, and keyword co-occurrence patterns. The analysis included annual publication outputs, country contributions, institutional productivity, author collaborations, journal distributions, and research hotspots. Results A total of 971 publications were identified, showing a significant increase in research output over the study period, particularly after 2014. China led in publication output (485 articles), followed by Japan (130 articles) and the United States (118 articles). China Medical University was the most productive institution (50 publications). The International Journal of Molecular Sciences, Cancers, and Oral Oncology were the primary publishing venues. Keyword analysis revealed an evolution from basic drug resistance mechanisms to emerging research areas including cancer stem cells, tumor microenvironment, and extracellular vesicles. Conclusions This bibliometric analysis demonstrates the rapid growth and evolving nature of oral cancer drug resistance research. The findings highlight the shift towards more sophisticated research areas and strong international collaboration patterns. These insights can guide future research directions and collaboration opportunities in this field.


  • Open Access

    Mendelian randomization analysis of environmental pollution factors and head and neck cancer risk: a causal inference study integrating autophagy-related genes

    by Xuejin Xu, Zhen Wang

    Background Head and neck squamous cell carcinoma (HNSC) is a significant global health challenge. While traditional risk factors are well-established, the role of environmental pollutants in HNSC development remains unclear. Objective To investigate the causal relationship between environmental pollution factors and HNSC risk using Mendelian Randomization (MR) analysis. Methods Two-sample MR analysis was performed using genome-wide association study data from the IEU OpenGWAS project and HNSC RNA-seq data from TCGA. Environmental pollution-associated genes (MRGs) were identified and analyzed along with autophagy-related genes (ATGs) in HNSC samples. Cox proportional hazards models were used to develop a clinical prediction model. Results MR analysis revealed significant causal relationships between nitrogen dioxide air pollution, nitrogen oxides air pollution, PM2.5, and increased HNSC risk. Nine MRGs were identified, with four (IRF4, LINGO1, PTHLH, RSRC1) differentially expressed in HNSC. A six-factor clinical prediction model (IRF4, LINGO1, PTHLH, RSRC1, Age, USP10) showed good predictive performance for HNSC survival (C-index = 0.63, 10-year AUC = 0.761). Tumor mutation burden and immune cell infiltration analyses provided further insights into HNSC biology. Conclusion This study provides evidence for causal relationships between specific air pollutants and HNSC risk, and identifies potential gene targets for further investigation. The developed clinical prediction model may aid in HNSC prognosis and personalized treatment strategies.